Shandong New Time Pharmaceutical Co., LTD

Works in Cardiovascular · Dermatology · GI & liver · Hematology · Immunology · Metabolic & endocrine · Musculoskeletal · Oncology · Renal & urogenital · Respiratory · Women's health

Shandong New Time Pharmaceutical Co., LTD is a clinical trial sponsor. It has 15 active clinical trials with 3,462 planned participants, across 11 therapeutic areas. Since 2021 it has completed 8 trials and stopped 0 early.

Trial track record · since 2021

15Active trials3,462 planned participants
8Completed0 with results posted
0Stopped early0% of finished trials

Pipeline · 15 active trials

StageTrialStatus

Questions about Shandong New Time Pharmaceutical Co., LTD

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-21.

Approve Suite is not affiliated with Shandong New Time Pharmaceutical Co., LTD.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.